{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:25:20Z","timestamp":1740122720910,"version":"3.37.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T00:00:00Z","timestamp":1589500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010803","name":"Department of Biotechnology, Government of West Bengal","doi-asserted-by":"publisher","award":["BT\/PR18249\/BIC\/101\/390\/2016"],"award-info":[{"award-number":["BT\/PR18249\/BIC\/101\/390\/2016"]}],"id":[{"id":"10.13039\/501100010803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s11030-020-10059-5","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T07:04:50Z","timestamp":1589526290000},"page":"801-810","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Data science-driven analyses of drugs inducing hypertension as an adverse effect"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3300-9832","authenticated-orcid":false,"given":"Reetu","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,15]]},"reference":[{"key":"10059_CR1","first-page":"23","volume":"436","author":"PR Lewis","year":"2015","unstructured":"Lewis PR, Karpa KD, Felix TM (2015) Adverse effects of common drugs: adults. FP Essent 436:23\u201330","journal-title":"FP Essent"},{"issue":"1","key":"10059_CR2","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","volume":"10","author":"F Cheng","year":"2019","unstructured":"Cheng F, Kov\u00e1cs IA, Barab\u00e1si A-L (2019) Network-based prediction of drug combinations. Nat Commun 10(1):1197","journal-title":"Nat Commun"},{"issue":"7019","key":"10059_CR3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nature03193","volume":"432","author":"C Lipinski","year":"2004","unstructured":"Lipinski C, Hopkins A (2004) Navigating chemical space for biology and medicine. Nature 432(7019):855\u2013861","journal-title":"Nature"},{"issue":"17","key":"10059_CR4","doi-asserted-by":"crossref","first-page":"6817","DOI":"10.1073\/pnas.1015024108","volume":"108","author":"PA Clemons","year":"2011","unstructured":"Clemons PA, Wilson JA, Dan\u010d\u00edk V, Muller S, Carrinski HA, Wagner BK, Koehler AN, Schreiber SL (2011) Quantifying structure and performance diversity for sets of small molecules comprising small-molecule screening collections. Proc Natl Acad Sci USA 108(17):6817\u20136822","journal-title":"Proc Natl Acad Sci USA"},{"issue":"44","key":"10059_CR5","doi-asserted-by":"crossref","first-page":"18787","DOI":"10.1073\/pnas.1012741107","volume":"107","author":"PA Clemons","year":"2010","unstructured":"Clemons PA, Bodycombe NE, Carrinski HA, Wilson JA, Shamji AF, Wagner BK, Koehler AN, Schreiber SL (2010) Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles. Proc Natl Acad Sci USA 107(44):18787\u201318792","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10059_CR6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","volume":"12","author":"A-L Barab\u00e1si","year":"2011","unstructured":"Barab\u00e1si A-L, Gulbahce N, Loscalzo J (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12(1):56\u201368","journal-title":"Nat Rev Genet"},{"key":"10059_CR7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.drudis.2013.01.008","volume":"18","author":"JL Medina-Franco","year":"2013","unstructured":"Medina-Franco JL, Giulianotti MA, Welmaker GS, Houghten RA (2013) Shifting from the single- to the multitarget paradigm in drug discovery. Drug Discov Today 18:495\u2013501","journal-title":"Drug Discov Today"},{"issue":"7","key":"10059_CR8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ddr.21034","volume":"73","author":"JL Medina-Franco","year":"2012","unstructured":"Medina-Franco JL (2012) Interrogating novel areas of chemical space for drug discovery using chemoinformatics. Drug Dev Res 73(7):430\u2013438","journal-title":"Drug Dev Res"},{"issue":"11","key":"10059_CR9","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/138955706778742768","volume":"6","author":"N Brown","year":"2006","unstructured":"Brown N, Jacoby E (2006) On scaffolds and hopping in medicinal chemistry. Mini-Rev Med Chem 6(11):1217\u20131229","journal-title":"Mini-Rev Med Chem"},{"key":"10059_CR10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13321-017-0212-4","volume":"9","author":"J Shang","year":"2017","unstructured":"Shang J, Sun H, Liu H, Chen F, Tian S, Pan P, Li D, Kong D, Hou T (2017) Comparative analyses of structural features and scaffold diversity for purchasable compound libraries. J Cheminform 9:25\u201340","journal-title":"J Cheminform"},{"issue":"3","key":"10059_CR11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cbpa.2010.02.018","volume":"14","author":"ME Welsch","year":"2010","unstructured":"Welsch ME, Snyder SA, Stockwell BR (2010) Privileged scaffolds for library design and drug discovery. Curr Opin Chem Biol 14(3):347\u2013361","journal-title":"Curr Opin Chem Biol"},{"issue":"15","key":"10059_CR12","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/jm9602928","volume":"39","author":"GW Bemis","year":"1996","unstructured":"Bemis GW, Murcko MA (1996) The properties of known drugs. J Med Chem 39(15):2887\u20132893","journal-title":"J Med Chem"},{"key":"10059_CR13","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3389\/fphar.2017.00880","volume":"8","author":"AK Sharma","year":"2017","unstructured":"Sharma AK, Srivastava GN, Roy A, Sharma VK (2017) ToxiM: a toxicity prediction tool for small molecules developed using machine learning and chemoinformatics approaches. Front Pharmacol 8:880\u2013897","journal-title":"Front Pharmacol"},{"key":"10059_CR14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.toxrep.2018.08.017","volume":"5","author":"C Limban","year":"2018","unstructured":"Limban C, Nu\u0163\u0103 DC, Chiri\u0163\u0103 C, Negre\u0219 S, Arsene AL, Goumenou M, Karakitsios SP, Tsatsakis AM, Sarigiannis DA (2018) The use of structural alerts to avoid the toxicity of pharmaceuticals. Toxicol Rep 5:943\u2013953","journal-title":"Toxicol Rep"},{"issue":"16","key":"10059_CR15","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1039\/C6GC01492E","volume":"18","author":"V Alves","year":"2016","unstructured":"Alves V, Muratov E, Capuzzi S, Politi R, Low Y, Braga R, Zakharov AV, Sedykh A, Mokshyna E, Farag S et al (2016) Alarms about structural alerts. Green Chem 18(16):4348\u20134360","journal-title":"Green Chem"},{"key":"10059_CR16","doi-asserted-by":"crossref","first-page":"104311","DOI":"10.1016\/j.phrs.2019.104311","volume":"154","author":"KR Beck","year":"2019","unstructured":"Beck KR, Thompson GR, Odermatt A (2019) Drug-induced endocrine blood pressure elevation. Pharmacol Res 154:104311","journal-title":"Pharmacol Res"},{"issue":"1","key":"10059_CR17","first-page":"10","volume":"18","author":"AF Rubio-Guerra","year":"2013","unstructured":"Rubio-Guerra AF, Rodriguez-Lopez L, Vargas-Ayala G, Huerta-Ramirez S, Serna DC, Lozano-Nuevo JJ (2013) Depression increases the risk for uncontrolled hypertension. Exp Clin Cardiol 18(1):10\u201312","journal-title":"Exp Clin Cardiol"},{"issue":"31","key":"10059_CR18","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/MD.0000000000001317","volume":"94","author":"Z Li","year":"2015","unstructured":"Li Z, Li Y, Chen L, Chen P, Hu Y (2015) Prevalence of depression in patients with hypertension. Medicine (Baltimore) 94(31):1317\u20131322","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10059_CR19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/ijms18030625","volume":"18","author":"OV Ancker","year":"2017","unstructured":"Ancker OV, Wehland M, Bauer J, Infanger M, Grimm D (2017) The adverse effect of hypertension in the treatment of thyroid cancer with multi-kinase inhibitors. Int J Mol Sci 18(3):625\u2013743","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10059_CR20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/HYPERTENSIONAHA.112.195149","volume":"59","author":"M Barton","year":"2012","unstructured":"Barton M, Prossnitz ER, Meyer MR (2012) Testosterone and secondary hypertension: new pieces to the puzzle. Hypertension 59(6):1101\u20131103","journal-title":"Hypertension"},{"issue":"1","key":"10059_CR21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.yrtph.2010.02.001","volume":"57","author":"J van Amsterdam","year":"2010","unstructured":"van Amsterdam J, Opperhuizen A, Hartgens F (2010) Adverse health effects of anabolic-androgenic steroids. Regul Toxicol Pharmacol 57(1):117\u2013123","journal-title":"Regul Toxicol Pharmacol"},{"issue":"4","key":"10059_CR22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.tjog.2013.10.035","volume":"52","author":"S-Y Chen","year":"2013","unstructured":"Chen S-Y, Fan S-Z, Chen L-K (2013) Ultralow dose combined spinal\u2013epidural anesthesia for cesarean section in ritodrine-related severe pulmonary hypertension. Taiwan J Obstet Gynecol 52(4):617","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"3","key":"10059_CR23","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1183\/09031936.02.02572001","volume":"20","author":"E Spiekerkoetter","year":"2002","unstructured":"Spiekerkoetter E, Fabel H, Hoeper MM (2002) Effects of inhaled salbutamol in primary pulmonary hypertension. Eur Respir J 20(3):524\u2013528","journal-title":"Eur Respir J"},{"issue":"10","key":"10059_CR24","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/ajh\/hpw055","volume":"29","author":"A Oskarsson","year":"2016","unstructured":"Oskarsson A, Uller\u00e5s E, Ohlsson Andersson \u00c5 (2016) Acetaminophen Increases Aldosterone Secretion While Suppressing Cortisol and Androgens: a Possible Link to Increased Risk of Hypertension. Am J Hypertens 29(10):1158\u20131164","journal-title":"Am J Hypertens"},{"key":"10059_CR25","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"V Law","year":"2014","unstructured":"Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, Maciejewski A, Arndt D, Wilson M, Neveu V et al (2014) DrugBank 4.0: shedding new light on drug metabolism. Nucl Acids Res 42:D1091\u2013D1097","journal-title":"Nucl Acids Res"},{"issue":"D1","key":"10059_CR26","doi-asserted-by":"crossref","first-page":"D158","DOI":"10.1093\/nar\/gkw1099","volume":"45","author":"The UniProt Consortium","year":"2017","unstructured":"The UniProt Consortium (2017) UniProt: the universal protein knowledgebase. Nucl Acids Res 45(D1):D158\u2013D169","journal-title":"Nucl Acids Res"},{"issue":"1","key":"10059_CR27","first-page":"9","volume":"4","author":"\u00d8 Hammer","year":"2001","unstructured":"Hammer \u00d8, Harper DAT, Ryan PD (2001) PAST: paleontological statistics software package for education and data analysis. Palaeontologia Electronica 4(1):9","journal-title":"Palaeontologia Electronica"},{"issue":"11","key":"10059_CR28","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","volume":"6","author":"PD Leeson","year":"2007","unstructured":"Leeson PD, Springthorpe B (2007) The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 6(11):881\u2013890","journal-title":"Nat Rev Drug Discov"},{"issue":"1\u20132","key":"10059_CR29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drudis.2006.11.011","volume":"12","author":"MG Siegel","year":"2007","unstructured":"Siegel MG, Vieth M (2007) Drugs in other drugs: a new look at drugs as fragments. Drug Discov Today 12(1\u20132):71\u201379","journal-title":"Drug Discov Today"},{"key":"10059_CR30","doi-asserted-by":"crossref","unstructured":"Dalvie D, Nair S, Kang P, Loi C-M (2010) Chapter 6: Influence of aromatic rings on ADME properties of drugs. In: metabolism, pharmacokinetics and toxicity of functional groups. The royal society of chemistry, pp 275\u2013327","DOI":"10.1039\/9781849731102-00275"},{"key":"10059_CR31","doi-asserted-by":"crossref","unstructured":"Worley JD (1993) Heterocyclic chemistry, second edition (Gilchrist, T.L.). J Chem Educ 70(3):A89","DOI":"10.1021\/ed070pA89.1"},{"issue":"10","key":"10059_CR32","first-page":"347","volume":"61","author":"J Adriani","year":"1972","unstructured":"Adriani J, Yarbrough WM (1972) Drugs containing halogen atoms: toxicity and lack of toxicity. J Med Assoc Georgia 61(10):347\u2013351","journal-title":"J Med Assoc Georgia"},{"issue":"3","key":"10059_CR33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/138945010790711996","volume":"11","author":"MZ Hernandes","year":"2010","unstructured":"Hernandes MZ, Cavalcanti SMT, Moreira DRM, de Azevedo Junior WF, Leite ACL (2010) Halogen atoms in the modern medicinal chemistry: hints for the drug design. Curr Drug Targets 11(3):303\u2013314","journal-title":"Curr Drug Targets"},{"issue":"3","key":"10059_CR34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1212\/WNL.0b013e3182074c2f","volume":"76","author":"EE Benarroch","year":"2011","unstructured":"Benarroch EE (2011) Na+, K+-ATPase: functions in the nervous system and involvement in neurologic disease. Neurology 76(3):287\u2013293","journal-title":"Neurology"},{"key":"10059_CR35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-3-319-24750-2_17","volume-title":"Regulation of membrane Na+-K+ATPase","author":"LM Nikolic","year":"2016","unstructured":"Nikolic LM (2016) Regulation of Na+\/K+-ATPase activity in the nervous system. In: Dhalla NS, Chakraborti S (eds) Regulation of membrane Na+-K+ATPase. Springer, Cham, pp 295\u2013309"},{"issue":"1","key":"10059_CR36","first-page":"25","volume":"51","author":"JC Shih","year":"1999","unstructured":"Shih JC, Chen K, Ridd MJ (1999) Role of MAO A and B in neurotransmitter metabolism and behavior. Pol J Pharmacol 51(1):25\u201329","journal-title":"Pol J Pharmacol"},{"issue":"12","key":"10059_CR37","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/CIRCRESAHA.113.301814","volume":"113","author":"Y-B Kim","year":"2013","unstructured":"Kim Y-B, Kim Yoon S, Kim Woong B, Shen F-Y, Lee Seung W, Chung Hyun J, Kim Jeong S, Han Hee C, Colwell Christopher S, Kim Yang I (2013) GABAergic excitation of vasopressin neurons. Circ Res 113(12):1296\u20131307","journal-title":"Circ Res"},{"key":"10059_CR38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nature06133","volume":"449","author":"E Zomot","year":"2007","unstructured":"Zomot E, Bendahan A, Quick M, Zhao Y, Javitch JA, Kanner BI (2007) Mechanism of chloride interaction with neurotransmitter: sodium symporters. Nature 449:726","journal-title":"Nature"},{"key":"10059_CR39","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11064-015-1776-x","volume":"41","author":"GA Czapski","year":"2016","unstructured":"Czapski GA, Czubowicz K, Strosznajder JB, Strosznajder RP (2016) The Lipoxygenases: their regulation and implication in alzheimer\u2019s disease. Neurochem Res 41:243\u2013257","journal-title":"Neurochem Res"},{"issue":"2","key":"10059_CR40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0896-6273(00)80953-8","volume":"19","author":"Y Li","year":"1997","unstructured":"Li Y, Maher P, Schubert D (1997) A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 19(2):453\u2013463","journal-title":"Neuron"},{"issue":"1","key":"10059_CR41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-biophys-060414-033901","volume":"44","author":"N Yan","year":"2015","unstructured":"Yan N (2015) Structural biology of the major facilitator superfamily transporters. Annu Rev Biophys 44(1):257\u2013283","journal-title":"Annu Rev Biophys"},{"issue":"Suppl 2","key":"10059_CR42","first-page":"93","volume":"9","author":"AM Olivares","year":"2016","unstructured":"Olivares AM, Moreno-Ramos OA, Haider NB (2016) Role of nuclear receptors in central nervous system development and associated diseases. J Exp Neurosci 9(Suppl 2):93\u2013121","journal-title":"J Exp Neurosci"},{"issue":"1","key":"10059_CR43","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/s41467-018-04266-w","volume":"9","author":"RW Manville","year":"2018","unstructured":"Manville RW, Papanikolaou M, Abbott GW (2018) Direct neurotransmitter activation of voltage-gated potassium channels. Nat Commun 9(1):1847","journal-title":"Nat Commun"},{"issue":"1","key":"10059_CR44","first-page":"119","volume":"133","author":"F Coceani","year":"1974","unstructured":"Coceani F (1974) Prostaglandins and the central nervous system. JAMA Internal Med 133(1):119\u2013129","journal-title":"JAMA Internal Med"},{"issue":"3","key":"10059_CR45","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62(3):405\u2013496","journal-title":"Pharmacol Rev"},{"key":"10059_CR46","first-page":"4314","volume":"7","author":"N Siddiqi","year":"2019","unstructured":"Siddiqi N, Shatat IF (2019) Antihypertensive agents: a long way to safe drug prescribing in children. Pediatr Nephrol 7:4314\u20134330","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10059_CR47","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/ajh\/hpw030","volume":"29","author":"GC Roush","year":"2016","unstructured":"Roush GC, Sica DA (2016) Diuretics for hypertension: a review and update. Am J Hypertens 29(10):1130\u20131137","journal-title":"Am J Hypertens"},{"key":"10059_CR48","doi-asserted-by":"crossref","first-page":"170180","DOI":"10.1016\/j.peptides.2019.170180","volume":"123","author":"MN Savitha","year":"2019","unstructured":"Savitha MN, Suvilesh KN, Siddesha JM, Gowda M, Choudhury M, Velmurugan D, Umashankar M, Vishwanath BS (2019) Combinatorial inhibition of angiotensin converting enyme, neutral endopeptidase and aminopeptidase n by n-methylated peptides alleviates blood pressure and fibrosis in rat model of dexamethasone-induced hypertension. Peptides 123:170180","journal-title":"Peptides"},{"key":"10059_CR49","first-page":"CD008170","volume":"1","author":"H Xue","year":"2015","unstructured":"Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GWK, Wright JM (2015) First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Cochrane Database Syst Rev 1:CD008170","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10059_CR50","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/HYPERTENSIONAHA.119.13700","volume":"74","author":"C Li","year":"2019","unstructured":"Li C, Yan X, Wu D, Zhang K, Liang X, Pan Y, Zhou Y, Chen F, Chen X, Yang S et al (2019) Vaccine targeted alpha 1d-adrenergic receptor for hypertension. Hypertension 74(6):1551\u20131562","journal-title":"Hypertension"},{"issue":"3","key":"10059_CR51","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.pharep.2017.01.028","volume":"69","author":"A Zablotskaya","year":"2017","unstructured":"Zablotskaya A, Segal I, Geronikaki A, Shestakova I, Nikolajeva V, Makarenkova G (2017) N-Heterocyclic choline analogues based on 1,2,3,4-tetrahydro(iso)quinoline scaffold with anticancer and anti-infective dual action. Pharmacol Rep 69(3):575\u2013581","journal-title":"Pharmacol Rep"},{"issue":"10","key":"10059_CR52","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.2174\/092986711795328382","volume":"18","author":"VR Solomon","year":"2011","unstructured":"Solomon VR, Lee H (2011) Quinoline as a privileged scaffold in cancer drug discovery. Curr Med Chem 18(10):1488\u20131508","journal-title":"Curr Med Chem"},{"issue":"15","key":"10059_CR53","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2174\/1389557519666190425184749","volume":"19","author":"AP Mishra","year":"2019","unstructured":"Mishra AP, Bajpai A, Rai AK (2019) 1,4-Dihydropyridine: a dependable heterocyclic ring with the promising and the most anticipable therapeutic effects. Mini Rev Med Chem 19(15):1219\u20131254","journal-title":"Mini Rev Med Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-020-10059-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-020-10059-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-020-10059-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T18:39:17Z","timestamp":1621363157000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-020-10059-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,15]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["10059"],"URL":"https:\/\/doi.org\/10.1007\/s11030-020-10059-5","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"type":"print","value":"1381-1991"},{"type":"electronic","value":"1573-501X"}],"subject":[],"published":{"date-parts":[[2020,5,15]]},"assertion":[{"value":"14 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}